We are live on ! Find out more
GS

Gagnon Securities Portfolio holdings

AUM $519M
1-Year Est. Return 44.91%
This Fund
S&P 500
This Quarter Est. Return
+8%
1 Year Est. Return
+44.91%
3 Year Est. Return
+129.38%
5 Year Est. Return
+108.07%
10 Year Est. Return
+1,389.15%
AUM
$360K
AUM Growth
-$231M
Cap. Flow
-$14.7M
Cap. Flow %
-4,071.13%
Top 10 Hldgs %
65.88%
Holding
103
New
8
Increased
23
Reduced
41
Closed
14

Sector Composition

Rank Sector Weight
1 Communication Services 38.9%
2 Technology 19.57%
3 Industrials 14.25%
4 Consumer Discretionary 6.18%
5 Healthcare 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYF icon
51
Synchrony
SYF
$25.8B
$423 0.12%
14,182
-81
-0.6% -$2.4K
JNJ icon
52
Johnson & Johnson
JNJ
$621B
$387 0.11%
2,924
SRGA
53
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$385 0.11%
2,192
-6,675
-75% -$949K
WRK
54
DELISTED
WestRock Company
WRK
$365 0.1%
6,441
DHI icon
55
D.R. Horton
DHI
$42.4B
$340 0.09%
9,839
CLAR icon
56
Clarus
CLAR
$129M
$333 0.09%
50,368
-24,725
-33% -$145K
IPHI
57
DELISTED
INPHI CORPORATION
IPHI
$324 0.09%
9,437
+836
+10% +$33.6K
URA icon
58
Global X Uranium ETF
URA
$5.94B
$320 0.09%
24,316
PFE icon
59
Pfizer
PFE
$147B
$306 0.08%
9,605
VNDA icon
60
Vanda Pharmaceuticals
VNDA
$306M
$296 0.08%
18,131
-60
-0.3% -$865
LEN icon
61
Lennar Class A
LEN
$21.2B
$292 0.08%
5,746
SONC
62
DELISTED
Sonic Corp
SONC
$276 0.08%
10,424
EOG icon
63
EOG Resources
EOG
$70.4B
$273 0.08%
3,018
+8
+0.3% +$737
CELG
64
DELISTED
Celgene Corp
CELG
$256 0.07%
1,968
-4
-0.2% -$490
PBI icon
65
Pitney Bowes
PBI
$2.51B
$222 0.06%
+14,731
New +$215K
BELFB
66
Bel Fuse Inc Class B
BELFB
$4.25B
$218 0.06%
8,811
CBK
67
DELISTED
Christopher & Banks Corporation
CBK
$218 0.06%
166,739
-644,821
-79% -$820K
URG
68
Ur-Energy
URG
$517M
$215 0.06%
343,084
CCJ icon
69
Cameco
CCJ
$41.1B
$193 0.05%
21,195
DNN icon
70
Denison Mines
DNN
$2.8B
$166 0.05%
+377,302
New +$192K
LPSN icon
71
LivePerson
LPSN
$26.1M
$143 0.04%
869
-117
-12% -$16.1K
AT
72
DELISTED
Atlantic Power Corporation
AT
$131 0.04%
54,742
-78,800
-59% -$196K
TTNP
73
DELISTED
Titan Pharmaceuticals
TTNP
$67 0.02%
+10
New +$93K
FLNA
74
Filana Therapeutics
FLNA
$46.4M
$65 0.02%
15,568
+8,813
+130% +$41.6K
SRNE
75
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$63 0.02%
31,586
+20,470
+184% +$39.9K

Similar funds

Gagnon Securities's Q2 2017 Portfolio in Review

As of Q2 2017, Gagnon Securities held 103 positions worth $360K, down 100% from $231M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Gagnon Securities withdrew a net $14.7M in Q2 2017, closing 14 positions and reducing 41 holdings. Its most notable exit was General Finance Corporation Senior Notes due 2021, an estimated $10.9M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 39% of assets, up from 6.2% a quarter earlier, followed by Technology and Industrials.

Against the trend, Gagnon Securities opened a new position in General Finance Corporation worth $10.9K.

  • Gagnon Securities's largest Q2 2017 buy was General Finance Corporation: 2,114,878 shares worth $10.9K.
  • Gagnon Securities added most to Instructure, Inc. in Q2 2017, an estimated $4.26M increase.
  • Gagnon Securities's biggest Q2 2017 reduction was Athenahealth, Inc., cutting an estimated $4.4M.
  • Gagnon Securities fully exited General Finance Corporation Senior Notes due 2021 in Q2 2017, selling an estimated $10.9M.
  • Gagnon Securities's ten largest holdings make up 66% of its $360K portfolio in Q2 2017.
  • Gagnon Securities opened 8 new positions and closed 14 in Q2 2017.
  • Gagnon Securities's portfolio value fell 100% quarter-over-quarter to $360K.

Based on Gagnon Securities's 13F filing for Q2 2017, filed 20 Jul 2017.